Asmanex Twisthaler (mometasone furoate inhalation powder, 220 mcg per actuation), 120 Metered Dos...

FDA Recall #D-0169-2024 — Class II — January 26, 2022

Recall #D-0169-2024 Date: January 26, 2022 Classification: Class II Status: Terminated

Product Description

Asmanex Twisthaler (mometasone furoate inhalation powder, 220 mcg per actuation), 120 Metered Doses, Rx only, Manufactured for: Organon LLC, a subsidiary of Organon & Co., Jersey City, NJ 07302; Manufactured by: MSD International GmbH (Singapore Branch) Singapore 638030, Singapore. NDC: 78206-114-01

Reason for Recall

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Recalling Firm

CARDINAL HEALTHCARE — Dublin, OH

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

3 units

Distribution

Nationwide USA

Code Information

Batch U027458

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated